Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02365766
Title Study of Neoadjuvant Pembrolizumab in Combination With Gemcitabine Based Therapy in Cis-eligible or -Ineligible Subjects With Urothelial Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Christopher Hoimes, M.D.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
IU Health Central Indiana Cancer Center Indianapolis Indiana 46219 United States Details
Community Regional Cancer Care Indianapolis Indiana 46256 United States Details
St. Vincent Hospital Indianapolis Indiana 46260 United States Details
Washington University: Siteman Cancer Center Saint Louis Missouri 63110 United States Details
University of New Mexico Cancer Center Albuquerque New Mexico 87106 United States Details
University Hospitals Seidman Cancer Center Cleveland Ohio 44106 United States Details
Thomas Jefferson University: Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field